We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2676
Albany International
AIN
$1.72B
| $1K | ﹤0.01% |
10
-74
| -88% | -$6.37K |
2021 Q2
3 quarters
|
|
2677
Gold.com Inc
GOLD
$1.16B
| $1K | ﹤0.01% |
+16
| New | +$546 |
2022 Q1
0 quarters
|
|
2678
Amarin Corp
AMRN
$239M
| $1K | ﹤0.01% |
10
| – | – |
2018 Q4
13 quarters
|
|
2679
Amerant Bancorp
AMTB
$1.14B
| $1K | ﹤0.01% |
+17
| New | +$563 |
2022 Q1
0 quarters
|
|
2680
AnaptysBio
ANAB
$1.42B
| $1K | ﹤0.01% |
47
+5
| +12% | +$151 |
2019 Q4
9 quarters
|
|
2681
Abercrombie & Fitch
ANF
$6.44B
| $1K | ﹤0.01% |
18
-86
| -83% | -$2.98K |
2021 Q1
4 quarters
|
|
2682
Alpha and Omega Semiconductor
AOSL
$687M
| $1K | ﹤0.01% |
17
-4
| -19% | -$208 |
2021 Q4
1 quarter
|
|
2683
American Outdoor Brands
AOUT
$231M
| $1K | ﹤0.01% |
83
| – | – |
2020 Q3
6 quarters
|
|
2684
Artisan Partners
APAM
$2.29B
| $1K | ﹤0.01% |
34
-8
| -19% | -$325 |
2021 Q3
2 quarters
|
|
2685
Ardelyx
ARDX
$808M
| $1K | ﹤0.01% |
1,000
| – | – |
2018 Q4
13 quarters
|
|
2686
Armour Residential REIT
ARR
$1.88B
| $1K | ﹤0.01% |
+22
| New | +$981 |
2022 Q1
0 quarters
|
|
2687
Array Technologies
ARRY
$545M
| $1K | ﹤0.01% |
108
-47
| -30% | -$528 |
2021 Q2
3 quarters
|
|
2688
Artesian Resources
ARTNA
$345M
| $1K | ﹤0.01% |
28
| – | – |
2020 Q3
6 quarters
|
|
2689
Arvinas
ARVN
$460M
| $1K | ﹤0.01% |
+18
| New | +$1.23K |
2022 Q1
0 quarters
|
|
2690
Ascendis Pharma A/S
ASND
$14.9B
| $1K | ﹤0.01% |
7
-115
| -94% | -$13.3K |
2021 Q3
2 quarters
|
|
2691
AST SpaceMobile
ASTS
$12.7B
| $1K | ﹤0.01% |
100
| – | – |
2021 Q2
3 quarters
|
|
2692
DELISTED
AtaiBeckley Inc
ATAI
| $1K | ﹤0.01% |
+100
| New | +$556 |
2022 Q1
0 quarters
|
|
2693
Atkore
ATKR
$3.21B
| $1K | ﹤0.01% |
14
| – | – |
2021 Q1
4 quarters
|
|
2694
Atlantic Union Bankshares
AUB
$5.45B
| $1K | ﹤0.01% |
17
-229
| -93% | -$9.15K |
2020 Q1
8 quarters
|
|
2695
American Vanguard Corp
AVD
$34.2M
| $1K | ﹤0.01% |
54
-190
| -78% | -$3.11K |
2021 Q3
2 quarters
|
|
2696
Barrett Business Services
BBSI
$774M
| $1K | ﹤0.01% |
+36
| New | +$608 |
2022 Q1
0 quarters
|
|
2697
Brink's
BCO
$4.32B
| $1K | ﹤0.01% |
18
+3
| +20% | +$205 |
2016 Q4
21 quarters
|
|
2698
Saul Centers
BFS
$727M
| $1K | ﹤0.01% |
27
+10
| +59% | +$490 |
2021 Q3
2 quarters
|
|
2699
BGC Group
BGC
$5.32B
| $1K | ﹤0.01% |
150
-2
| -1% | -$9 |
2019 Q2
11 quarters
|
|
2700
Smartbird Inc
BIRD
$28.1M
| $1K | ﹤0.01% |
+5
| New | +$984 |
2022 Q1
0 quarters
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.